Manulife (MFC, 945) Announces Refreshed Strategy and India Expansion

Bulletin Express
Nov 13, 2025

Manulife introduced a refreshed enterprise strategy aimed at achieving long-term, sustainable growth and unveiled an ambition to become the number one choice for customers. The strategy sets five new and elevated priorities, focused on fostering a winning team and culture, maintaining a diversified business portfolio, empowering customer health, wealth, and longevity, advancing as an AI-powered organization, and strengthening distribution.

The renewed approach builds on Manulife’s current momentum toward its 2027 targets, which include a core return on equity above 18%, cumulative remittances exceeding US$22 billion between 2024 and 2027, and an Asia region core earnings contribution reaching 50%. The initiatives are anchored in Manulife’s desire to capture opportunities presented by changing market conditions, intensified competition, and new demographic trends.

An important focus of the refreshed strategy is longevity, with Manulife launching the Manulife Longevity Institute. Backed by a US$350 million commitment through 2030, the institute will pursue research, advocacy, and community investment to help people live healthier and more financially secure lives.

In addition, Manulife announced plans to expand its global footprint to India through a joint venture with its existing partner Mahindra, pending regulatory approvals. This proposed market entry is intended to capitalize on a high-growth economy and enhance Manulife’s diversified presence across key markets in Asia and North America.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10